Synthetic Blood International (SYBD) is set to capitalize on strong blood substitutes market

To read the complete article, please visit http://www.beaconequityresearch.com

More than 4.5 million patients need blood transfusions each year in the US and Canada. Every three seconds someone needs a blood transfusion, while on average, one out of every 7 people entering the hospital will need blood. About 37 out of every 100 Americans are eligible to donate blood – while only 3 to 4 people out of every 100 actually donate each year.

One of those companies involved in research of blood substitute is Synthetic Blood International (SYBD). The Company is currently developing Oxycyte™, a product based on perfluorocarbons, which is believed to be a safe and effective alternative to transfused blood. Compared with hemoglobin, Oxycyte has been found to be capable of carrying at least five times more oxygen. This is achieved due to the much smaller particles of Oxycyte than hemoglobin. According to the Company, the perfluorocarbon microdroplets that carry the oxygen are 1/70th the size of the red cells. They can therefore reach many areas of the body that human hemoglobin cells cannot.

According to Robert Larsen, Interim President and CEO of SYBD, Oxycyte is an exciting potential alternative method to more effectively transport oxygen to tissues such as the heart and brain, which due to injury, may be oxygen-starved. Oxycyte could be used in surgery, trauma, angioplasty, open heart surgery, and oxygenation of tumors during radiation or chemotherapy. The product can also be used on the battlefield, at the scene of accidents, and stored in emergency vehicles.

To read the complete article, please visit http://www.beaconequityresearch.com

Beacon Equity Research Gainers are Broadcom Corp (Nasdaq: BRCM), Intel (Nasdaq: INTC), Sirius Satellite (Nasdaq: SIRI), Cisco Systems (Nasdaq: CSCO), Apple Inc (Nasdaq: AAPL), Yahoo Inc. (Nasdaq: YHOO), and Microsoft (Nasdaq: MSFT).

Beacon Equity Research Decliners are Comcast (Nasdaq: CMCSA), Research in Motion (Nasdaq: RIMM), Force Protection (Nasdaq: FRPT), Level 3 (Nasdaq: LVLT), Ebay (Nasdaq: EBAY), Fuel Cell Energy(Nasdaq: FCEL), and Marvel Tech (Nasdaq: MRVL).

Contact Information

Jeff Bishop

Editor

Beacon Equity Research

Contact via E-mail